Oral antiviral (OAV)
Showing 1 - 25 of >10,000
Chronic Hepatitis B Trial in Baltimore, Auckland (Selgantolimod, Placebo, Hepatitis B virus (HBV) OAV Therapy)
Chronic Hepatitis B Trial in Seoul (Standard of care)
Active, not recruiting
- Chronic Hepatitis B
- Standard of care
-
Seoul, Korea, Republic of
- +3 more
Mar 29, 2023
Real World COVID-19 Antiviral Effectiveness Research
Not yet recruiting
- COVID-19
- Oral Antiviral
- (no location specified)
Dec 4, 2022
Chronic Hepatitis b Trial in Beijing, Chongqing (STSG-0002 Injection)
Not yet recruiting
- Chronic Hepatitis b
- STSG-0002 Injection
-
Beijing, Beijing, China
- +3 more
Mar 6, 2023
Chronic Hepatitis b Trial in Beijing, Chongqing (STSG-0002 Injection)
Not yet recruiting
- Chronic Hepatitis b
- STSG-0002 Injection
-
Beijing, Beijing, China
- +3 more
Mar 6, 2023
After Long-Term Antiviral Treatment for Chronic Hepatitis B
Completed
- Chronic Hepatitis B e Antigen Positive
- Chronic Hepatitis B e Antigen Negative
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Hepatitis B, Chronic, Adherence, Medication, Quality of Life Trial (effectiveness of education)
Not yet recruiting
- Hepatitis B, Chronic
- +2 more
- effectiveness of education
- (no location specified)
Mar 17, 2022
HIV Trial (Oral Vitamin C)
Withdrawn
- HIV Infections
- Oral Vitamin C
- (no location specified)
Oct 28, 2021
Lower Respiratory Tract Infection, Upper Respiratory Tract Infection Trial in Dunedin (Streptococcus salivarius K12 Powder 1
Recruiting
- Lower Respiratory Tract Infection
- Upper Respiratory Tract Infection
- Streptococcus salivarius K12 Powder 1 Billion colony forming units /g)
- +3 more
-
Dunedin, Otago, New ZealandBlis Technologies Ltd
May 11, 2022
Stopping Antiviral Treatment in Chronic Hepatitis B
Recruiting
- Chronic Hepatitis b
-
Hong Kong, Please Select One ..., Hong KongMan Fung Yuen
Sep 28, 2021
Dengue Trial in Baltimore, Burlington (JNJ-64281802 (sentinel high dose), JNJ-64281802 (remaining high dose), JNJ-64281802
Recruiting
- Dengue
- JNJ-64281802 (sentinel high dose)
- +6 more
-
Baltimore, Maryland
- +1 more
May 11, 2022
Corona Virus Infection, Middle East Respiratory Syndrome (MERS), Acute Respiratory Distress Syndrome Trial in Cairo (Lactoferrin
Not yet recruiting
- Corona Virus Infection
- +5 more
- Lactoferrin (Apolactoferrin)
- Placebo of excipient(s) will be administered
-
Cairo, Giza, Egypt
- +3 more
Nov 12, 2021
Hiv, Hormone Therapy Trial in San Diego (Emtricitabine / Tenofovir Disoproxil Oral Tablet 200/300 mg, Emtricitabine Tenofovir
Completed
- Hiv
- Hormone Therapy
- Emtricitabine / Tenofovir Disoproxil Oral Tablet 200/300 mg
- Emtricitabine Tenofovir Alafenamide 200/25 mg
-
San Diego, CaliforniaUC San Diego AntiViral Research Center (AVRC)
Sep 21, 2022
COVID-19, Coronavirus Infection, SARS CoV 2 Infection Trial in Chapel Hill (Placebo Comparator: Sterile Water, 27% Ethanol plus
Recruiting
- COVID-19
- +2 more
- Placebo Comparator: Sterile Water
- +2 more
-
Chapel Hill, North CarolinaGeneral and Oral Health Center
Feb 7, 2022
Healthy Trial in Syracuse (Placebo, JNJ-64281802 High dose, JNJ-64281802 Medium dose)
Suspended
- Healthy
- Placebo
- +6 more
-
Syracuse, New YorkSUNY Upstate Medical University
Mar 23, 2022
Covid19, Coronavirus Infection, SARS-CoV-2 Infection Trial in Chapel Hill (Saline, 1.5% w/v Hydrogen Peroxide, 0.12%
Terminated
- Covid19
- +2 more
- Saline
- +5 more
-
Chapel Hill, North CarolinaGeneral and Oral Health Center
Sep 26, 2022
Hepatitis B, HIV Trial in Worldwide (Selgantolimod, Placebo)
Recruiting
- Hepatitis B
- HIV Infections
- Selgantolimod
- Placebo
-
San Diego, California
- +35 more
Jan 31, 2023
HIV Trial in Worldwide (Darunavir (DRV) 800 milligram (MG) Oral Tablet, Ritonavir 100 MG Oral Tablet, N(t)RTIs)
Recruiting
- HIV Infections
- Darunavir (DRV) 800 milligram (MG) Oral Tablet
- +6 more
-
Chennai, India
- +6 more
Aug 30, 2021
Metabolic Syndrome on Antiviral Response in People With Chronic
Not yet recruiting
- Chronic Hepatitis b
- (no location specified)
Jan 21, 2023
Chronic Hepatitis B Trial in Daegu (Experimental)
Completed
- Chronic Hepatitis B
-
Daegu, Korea, Republic ofDaegu Chatholic University Medical center
Jul 26, 2021
HIV-1-infection Trial (Cabotegravir/Rilpivirine, Antiretroviral)
Recruiting
- HIV-1-infection
-
Kisumu, Kenya
- +6 more
Feb 1, 2023